Cancer and stroke: commonly encountered by clinicians, but little evidence to guide clinical approach
M Woock, N Martinez-Majander… - Therapeutic …, 2022 - journals.sagepub.com
The association between stroke and cancer is well-established. Because of an aging
population and longer survival rates, the frequency of synchronous stroke and cancer will …
population and longer survival rates, the frequency of synchronous stroke and cancer will …
Pulmonary embolism in the cancer associated thrombosis landscape
G Poenou, T Dumitru Dumitru, L Lafaie… - Journal of Clinical …, 2022 - mdpi.com
In cancer patients, pulmonary embolism (PE) is the second leading cause of death after the
cancer itself, most likely because of difficulties in diagnosing the disease due to its …
cancer itself, most likely because of difficulties in diagnosing the disease due to its …
Ischemic stroke in patients with malignancy
Approximately one-quarter to one-third of patients with ischemic stroke have an embolic
stroke of undetermined source (ESUS). An estimated 5% to 10% of patients with ESUS have …
stroke of undetermined source (ESUS). An estimated 5% to 10% of patients with ESUS have …
[HTML][HTML] Thrombotic complications in patients with cancer: Advances in pathogenesis, prevention, and treatment—A report from ICTHIC 2021
A Falanga, B Brenner, AA Khorana… - Research and Practice in …, 2022 - Elsevier
Venous thromboembolism (VTE) is a common complication in cancer patients, resulting in
deep vein thrombosis (DVT) or pulmonary embolism (PE), and is responsible for high …
deep vein thrombosis (DVT) or pulmonary embolism (PE), and is responsible for high …
Recurrent venous thromboembolism
HR Mount, M Rich, MS Putnam - American Family Physician, 2022 - aafp.org
Venous thromboembolism (VTE) recurrence rates are three times higher in patients with
chronic or no risk factors compared with those who have transient risk factors after stopping …
chronic or no risk factors compared with those who have transient risk factors after stopping …
Thrombosis and anticoagulation: clinical issues of special importance to hematologists who practice in Asia
K Boonyawat, P Angchaisuksiri - Hematology, 2022 - ashpublications.org
There are clinical issues of special importance and practice variation in the management of
venous thromboembolism (VTE) and in the use of anticoagulants among hematologists who …
venous thromboembolism (VTE) and in the use of anticoagulants among hematologists who …
The conundrum of occult cancer screening in venous thromboembolism: lessons from the REMOTEV registry
EM Cordeanu, L Jambert, J Tousch, C Mirea, A Delatte… - Medicina, 2022 - mdpi.com
(1) Background and Objectives: Venous thromboembolism (VTE) is strongly associated with
cancer, and may be the first event revealing occult neoplasia. Nonetheless, the reasonable …
cancer, and may be the first event revealing occult neoplasia. Nonetheless, the reasonable …
Adherence to guideline-recommended cancer screening in stroke survivors: a nationwide analysis
M Simonetto, S Rutrick, NM LeMoss… - Journal of Stroke and …, 2022 - Elsevier
Objectives Cancer can present as stroke. Several cancer types have established screening
guidelines. We investigated adherence to guideline-recommended cancer screening in …
guidelines. We investigated adherence to guideline-recommended cancer screening in …
Venous thromboembolism and critical limb events in patients with atrial fibrillation: a nationwide population-based cohort study
MS Lin, CM Chung, MY Chen, PH Chu… - …, 2022 - journals.sagepub.com
Little is known about whether venous thromboembolism (VTE) causes worse critical limb
events in populations with atrial fibrillation (AF). A retrospective cohort study using claims …
events in populations with atrial fibrillation (AF). A retrospective cohort study using claims …